| Dr Katia Christine Korte, MD | |
|
130 Quincy Ave, Brockton, MA 02302-2803 | |
| (508) 941-7268 | |
| (508) 941-7850 |
| Full Name | Dr Katia Christine Korte |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 22 Years |
| Location | 130 Quincy Ave, Brockton, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083942270 | NPI | - | NPPES |
| 110097726A | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 255569 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Accentcare Home Health Of Massachusetts | Westwood, MA | Home health agency |
| Kindred At Home | Fall river, MA | Home health agency |
| Nightingale Visiting Nurses | Taunton, MA | Home health agency |
| Caretenders | Needham heights, MA | Home health agency |
| Amedisys Home Health Care | Lawrence, MA | Home health agency |
| Morton Hospital | Taunton, MA | Hospital |
| Good Samaritan Medical Center | Brockton, MA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Steward Medical Group Inc | 2860688728 | 1404 |
News Archive
Presidio Pharmaceuticals, Inc. announced today that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has authorized the initiation of a Phase 1 first-in-human clinical trial of PPI-461, an orally administered NS5A inhibitor for the treatment of hepatitis C virus (HCV). The Phase 1 clinical trial will be conducted in healthy volunteers.
Persons with the serious disorder ALS, can have a genetic mutation that causes the protein SOD1 to aggregate in motor neurons in the brain and spinal cord. Researchers at Umea University have discovered that, when injected into mice, the SOD1 aggregation spreads rapidly leading to ALS. The discovery has been described in the Journal of Clinical Investigation.
Research led by the University of Leicester and University Hospitals of Leicester NHS Trust has provided a new advance in predicting a potentially serious pregnancy complication.
With each new publication of coronary artery disease (CAD) data from the Women's Health Initiative (WHI) study, the inevitable reaction is ,Why on earth did the WHI investigators claim in 2002-2004 that postmenopausal hormone therapy has deleterious effects on the risk for CAD, when, from the beginning, they were aware of the importance of the age factor in this clinical scenario".
The proposed link between caffeine and reductions in the beta amyloid plaque accumulation characteristic of Alzheimer's disease (AD) suggest a possible role for caffeine in AD treatment. The latest evidence linking beta amyloid protein to Alzheimer's disease and exploring the relationship between caffeine and beta amyloid are featured in a review article in Journal of Caffeine Research: The International Multidisciplinary Journal of Caffeine Science, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
› Verified 5 days ago
| Entity Name | Taunton Medical Center, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811987720 PECOS PAC ID: 7012978893 Enrollment ID: O20041025000771 |
News Archive
Presidio Pharmaceuticals, Inc. announced today that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has authorized the initiation of a Phase 1 first-in-human clinical trial of PPI-461, an orally administered NS5A inhibitor for the treatment of hepatitis C virus (HCV). The Phase 1 clinical trial will be conducted in healthy volunteers.
Persons with the serious disorder ALS, can have a genetic mutation that causes the protein SOD1 to aggregate in motor neurons in the brain and spinal cord. Researchers at Umea University have discovered that, when injected into mice, the SOD1 aggregation spreads rapidly leading to ALS. The discovery has been described in the Journal of Clinical Investigation.
Research led by the University of Leicester and University Hospitals of Leicester NHS Trust has provided a new advance in predicting a potentially serious pregnancy complication.
With each new publication of coronary artery disease (CAD) data from the Women's Health Initiative (WHI) study, the inevitable reaction is ,Why on earth did the WHI investigators claim in 2002-2004 that postmenopausal hormone therapy has deleterious effects on the risk for CAD, when, from the beginning, they were aware of the importance of the age factor in this clinical scenario".
The proposed link between caffeine and reductions in the beta amyloid plaque accumulation characteristic of Alzheimer's disease (AD) suggest a possible role for caffeine in AD treatment. The latest evidence linking beta amyloid protein to Alzheimer's disease and exploring the relationship between caffeine and beta amyloid are featured in a review article in Journal of Caffeine Research: The International Multidisciplinary Journal of Caffeine Science, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
› Verified 5 days ago
| Entity Name | Steward Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629398219 PECOS PAC ID: 2860688728 Enrollment ID: O20101119000007 |
News Archive
Presidio Pharmaceuticals, Inc. announced today that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has authorized the initiation of a Phase 1 first-in-human clinical trial of PPI-461, an orally administered NS5A inhibitor for the treatment of hepatitis C virus (HCV). The Phase 1 clinical trial will be conducted in healthy volunteers.
Persons with the serious disorder ALS, can have a genetic mutation that causes the protein SOD1 to aggregate in motor neurons in the brain and spinal cord. Researchers at Umea University have discovered that, when injected into mice, the SOD1 aggregation spreads rapidly leading to ALS. The discovery has been described in the Journal of Clinical Investigation.
Research led by the University of Leicester and University Hospitals of Leicester NHS Trust has provided a new advance in predicting a potentially serious pregnancy complication.
With each new publication of coronary artery disease (CAD) data from the Women's Health Initiative (WHI) study, the inevitable reaction is ,Why on earth did the WHI investigators claim in 2002-2004 that postmenopausal hormone therapy has deleterious effects on the risk for CAD, when, from the beginning, they were aware of the importance of the age factor in this clinical scenario".
The proposed link between caffeine and reductions in the beta amyloid plaque accumulation characteristic of Alzheimer's disease (AD) suggest a possible role for caffeine in AD treatment. The latest evidence linking beta amyloid protein to Alzheimer's disease and exploring the relationship between caffeine and beta amyloid are featured in a review article in Journal of Caffeine Research: The International Multidisciplinary Journal of Caffeine Science, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Katia Christine Korte, MD 54 Court St, Taunton, MA 02780-3201 Ph: (508) 821-2500 | Dr Katia Christine Korte, MD 130 Quincy Ave, Brockton, MA 02302-2803 Ph: (508) 941-7268 |
News Archive
Presidio Pharmaceuticals, Inc. announced today that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has authorized the initiation of a Phase 1 first-in-human clinical trial of PPI-461, an orally administered NS5A inhibitor for the treatment of hepatitis C virus (HCV). The Phase 1 clinical trial will be conducted in healthy volunteers.
Persons with the serious disorder ALS, can have a genetic mutation that causes the protein SOD1 to aggregate in motor neurons in the brain and spinal cord. Researchers at Umea University have discovered that, when injected into mice, the SOD1 aggregation spreads rapidly leading to ALS. The discovery has been described in the Journal of Clinical Investigation.
Research led by the University of Leicester and University Hospitals of Leicester NHS Trust has provided a new advance in predicting a potentially serious pregnancy complication.
With each new publication of coronary artery disease (CAD) data from the Women's Health Initiative (WHI) study, the inevitable reaction is ,Why on earth did the WHI investigators claim in 2002-2004 that postmenopausal hormone therapy has deleterious effects on the risk for CAD, when, from the beginning, they were aware of the importance of the age factor in this clinical scenario".
The proposed link between caffeine and reductions in the beta amyloid plaque accumulation characteristic of Alzheimer's disease (AD) suggest a possible role for caffeine in AD treatment. The latest evidence linking beta amyloid protein to Alzheimer's disease and exploring the relationship between caffeine and beta amyloid are featured in a review article in Journal of Caffeine Research: The International Multidisciplinary Journal of Caffeine Science, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
› Verified 5 days ago
Louis D. Gottlieb, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 680 Centre St, Managed Care, Brockton, MA 02302 Phone: 508-941-7065 Fax: 508-941-6373 | |
Gloria Ibarra, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 63 Main St, Brockton, MA 02301 Phone: 508-559-6699 Fax: 508-559-5073 | |
Elsie Varughese, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 63 Main St, Brockton, MA 02301 Phone: 508-559-6699 Fax: 508-583-4649 | |
Jane G Butlin, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Pearl St, Suite 2200, Brockton, MA 02301 Phone: 508-897-6051 Fax: 508-897-6096 | |
Jacob Mandell, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 680 Centre St, Brockton Hospital, Brockton, MA 02302 Phone: 508-941-7150 | |
Jolly Abeskheron, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Pearl St, Suite 1000, Brockton, MA 02301 Phone: 508-897-6060 Fax: 508-897-6063 | |
Xin He, Internal Medicine Medicare: Medicare Enrolled Practice Location: 110 Liberty St, Brockton, MA 02301 Phone: 508-894-0400 |